logo
Publix Food Recall Update as FDA Issues Arsenic Warning

Publix Food Recall Update as FDA Issues Arsenic Warning

Newsweek3 days ago

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources.
Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content.
The U.S. Food and Drug Administration (FDA) has classified a Publix recall of a popular baby food item as a Class II recall, citing elevated levels of lead, cadmium and arsenic in the product.
The affected item, the "Greenwise Pear Kiwi Spinach & Pea Baby Food Pouch," was distributed across eight Southern states.
Newsweek has contacted Publix outside of regular working hours via email for comment.
Why It Matters
The FDA's Class II recall designation means the agency believes exposure to the product may cause temporary or medically reversible adverse health consequences, or that the probability of serious health issues is remote but not negligible.
Heavy metals like lead, cadmium and arsenic are toxic at elevated levels and particularly dangerous when consumed over time by vulnerable groups such as infants. Long-term exposure may contribute to developmental delays, lower IQ and behavioral issues in children.
While not as urgent as a Class I recall, the Class II designation still indicates a serious public health matter that warrants consumer caution and attention.
A file photo shows a baby being fed.
A file photo shows a baby being fed.
Anthony Devlin/Press Association via AP
What To Know
The recall was initiated by Publix on May 9 and was classified by the FDA on June 3.
The affected product, the "Greenwise Pear Kiwi Spinach & Pea Baby Food Pouch," comes in a 4 oz pouch, and is marketed for babies aged six months or older.
The product has a "Best if used by" date of November 1, 2025, and was packed in cases of 14 pouches. They had a lot code of 24BA306.
The baby food pouches were distributed across the states of Florida, Georgia, South Carolina, North Carolina, Tennessee, Alabama, Virginia and Kentucky. A total of 53,620 units were distributed, which equated to 3,830 cases.
What People Are Saying
Publix Director of Communications Maria Brous said: "As part of our commitment to food safety, potentially impacted products have been removed from all store shelves. To date, there have been no reported cases of illness. Consumers who have purchased the product in question may return the product to their local store for a full refund. Publix customers with additional questions may call our customer care department toll-free at 1-800-242-1227 or visit our website at publix.com."
First Focus on Children, a bipartisan advocacy organization, wrote on its website: "Heavy metals can contaminate food products at many steps of the food production process. Some heavy metals are introduced through fertilizers and insecticides, while other heavy metals occur naturally in soil and are absorbed by plants. Runoff from roads, factories, and dumping grounds can also pollute water sources used for crops. In addition to the agricultural process, heavy metals can be introduced into food products through fortified vitamins and minerals that are added during the manufacturing process."
What's Next
The recall remains ongoing. Consumers are urged to check packaging for the product label and best-by date and to avoid feeding the product to children under any circumstance.
Parents or caregivers who believe a child has consumed the recalled product and is exhibiting symptoms are advised to consult a pediatrician immediately.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

US Close to High-Speed Rail Breakthrough
US Close to High-Speed Rail Breakthrough

Newsweek

time34 minutes ago

  • Newsweek

US Close to High-Speed Rail Breakthrough

Based on facts, either observed and verified firsthand by the reporter, or reported and verified from knowledgeable sources. Newsweek AI is in beta. Translations may contain inaccuracies—please refer to the original content. When the great and the good of the American high speed rail industry gathered in Washington, D.C. over May 13-15 for the U.S. High Speed Rail Association's (USHSR) 2025 annual conference, there was tremendous excitement tinged with anxiety. Several attendees told Newsweek they believe the U.S. could be on the verge of a high-speed rail breakthrough, setting the stage for the kind of comprehensive national system enjoyed in the likes of China, Japan and Western Europe. Ray LaHood, a Republican who served as Transportation Secretary under President Obama from 2009 to 2013, said if one of the two high-speed rail lines currently under construction is completed, it will prove "wildly popular" and boost support for high-speed rail across the nation. Other insiders agreed, but argued permitting reform and more explicit federal support will be needed first. There has been concern over the Trump administration's attitude toward high-speed rail. The conference took place one month after Transportation Secretary Sean P. Duffy announced $63.9 million in funding for a proposed Dallas to Houston route had been scrapped, and amid rumors that the California High Speed Rail line under construction between Los Angeles and San Francisco could lose federal support. This week, Duffy said there is "no viable path" to complete California High Speed Rail on time or on budget and warned the federal government could pull billions in funding. State of U.S. High-Speed Rail At present there aren't any high-speed rail networks—defined by the International Union of Railways (UIC) as operating at a minimum of 250 kilometers per hour (155 miles per hour) along specially built tracks—that are operational in the U.S. This compares unfavorably with the likes of Spain, Japan and France, which have around 2,460 miles, 1,830 miles and 1,740 miles of track respectively currently in use. Former Transportation Secretary Ray LaHood predicted the first high-speed rail line in the U.S. will be "wildly popular." Former Transportation Secretary Ray LaHood predicted the first high-speed rail line in the U.S. will be "wildly popular." Photo-illustration by Newsweek/Getty/Canva Most impressively, China, the chief geopolitical rival of the U.S., has gone from having virtually no high-speed rail lines to nearly 30,000 miles over the past couple of decades. Construction is currently underway on two high-speed rail lines in the U.S.—Brightline West, which will connect Las Vegas to Southern California, and California High Speed Rail between Los Angeles and San Francisco. A range of other projects have been proposed around the country, including plans to link Boston, New York and Washington, D.C. in the Northeast; Dallas, Houston and Fort Worth in Texas; and Chicago to East St. Louis in Illinois. Obstacles When asked why the U.S. had failed to build a high-speed network comparable to other advanced economies, industry experts told Newsweek there are major issues with permitting, financing and cross-party political support. California High Speed Rail has sparked particular controversy, with its cost ballooning from $34 billion to over $128 billion, while the completion date has been pushed back. Terry Hynes, an attorney specializing in rail infrastructure projects, argued planning issues in particular have bottled up capital investment. He is currently part of a team investigating how the permitting process could be sped up for USHSR. Addressing Newsweek, he said: "I've been in the business 46 years, making railroads, and I've been frustrated as hell representing the high-speed just takes forever. And there's private money that could be brought in. Wall Street's got a lot of money looking for infrastructure investments. "This is a wonderful infrastructure investment, the trouble is they see those permitting times. Eight years for environmental review, then you build for four years and in year 13 you're finally going to see some money. Nobody's going to invest in that." Former Obama era Transportation Secretary Ray LaHood speaking at the U.S. High Speed Rail Association's 2025 annual conference. Former Obama era Transportation Secretary Ray LaHood speaking at the U.S. High Speed Rail Association's 2025 annual conference. James Bickerton/Newsweek Hynes added: "The biggest issue to my mind is this permitting issue. The review period takes so long, the cost goes up and the more expensive it is for people doing a cost-benefit analysis, the analyses looks less beneficial." Brandon Wheeler, a senior program manager at the North Central Texas Council of Governments, a local government-based voluntary association, said a lack of national leadership has undermined high-speed rail construction across the U.S. Speaking to Newsweek, he said: "We don't have a national single point of leadership on that single point of leadership it really is a little bit hopscotch and we're making the best we can of it. "Until there is, like the interstate highway system, there's a national vision to create and you have a vision around the ability to move military and goods and those kinds of things. Until our airports get bad enough, until our roads get bad enough, until people have this massive outcry and we're able to concentrate them on something, we're going to have to find what that single vision is to rally around or we will fall behind the rest of the world." LaHood agreed, saying: "I think the success of these projects in Europe and Asia is largely due to the national government making investments but then encouraging the private sector. Once the national government makes a commitment, it's easier for the private sector then—they know it's going to be a stable project, they know their investment is going to be good." If You Build It They Will Come In 2023, Brightline, the first privately built rail line in the U.S. to open in nearly a century, began operations between Miami and Orlando in Florida and has since seen passenger numbers surge. While Brightline runs below the high-speed standard, LaHood said it showed Americans are ready to embrace new rail networks, and argued one successful project in the U.S. could turbocharge the whole industry. "If you look at the Brightline project in is wildly popular," he said. "They're putting more and more trains on that track every day because people like the idea that they don't have to get on the I95 and they don't have to travel on highways that are crowded with big trucks and cars... The U.S. High Speed Rail Association's 2025 annual conference in Washington, D.C. The U.S. High Speed Rail Association's 2025 annual conference in Washington, D.C. James Bickerton/Newsweek "If you build it they will come, if you build it it will be successful and I think that will be the case with Brightline West, Las Vegas to L.A., and I think it will be true San Francisco to L.A. I think they will be wildly popular. I really believe at this point if you build it they will come and the proof of that is Europe and Asia—their trains are wildly popular." Speaking to Newsweek, Portland Mayor Keith Wilson, who is advocating for a "Cascadia" high-speed rail line linking the city to Seattle in Washington and Vancouver in British Columbia, said: "Our system continues to be compacted and stagnant. "The great cities from around the world are all tending to go towards high-speed rail and we need an opportunity to unlock our economic renaissance, which is what's missing in our country right now, and high-speed rail would move us forward and get us completing again with the world." Trust Fund A number of industry insiders told Newsweek the formation of a federal government trust fund could provide the financial muscle for a major U.S. high-speed rail expansion. Asked what one development would most speed up U.S. high-speed rail, Jim Derwinski, executive director of Chicago rail system Metra, replied: "A trust fund so it's national, it's bipartisan so it doesn't change from administration to administration and it can be supported through the states as a national effort. "If you're going to build something, to compare it to Europe and Asia right now, it's got to have a national campaign right now." Arthur Sohikian is executive director of High Desert Corridor, a proposed high-speed rail line that would link Brightline West to the California High Speed Rail line. He expressed a similar view to Derwinski, telling Newsweek: "We have to energize the public to make that been trying to get a trust fund for rail since I started my career, it seems. "For whatever reason why the politicians won't grab onto that and won't do that, especially when you realize the Highway Trust Fund keeps diminishing as cars get more efficient, we're paying less in gas taxes, that fund is have to invest in this infrastructure as a nation, and until that happens, seriously, we're all going to be trying to do our little pieces." The U.S. High Speed Rail Association paid travel and hotel expenses for Newsweek reporter James Bickerton to attend its 2025 annual conference.

ProZenith Launches Natural Supplement Formulated for Weight Management Support
ProZenith Launches Natural Supplement Formulated for Weight Management Support

Business Upturn

time37 minutes ago

  • Business Upturn

ProZenith Launches Natural Supplement Formulated for Weight Management Support

By GlobeNewswire Published on June 7, 2025, 06:50 IST Aurora, June 06, 2025 (GLOBE NEWSWIRE) — ProZenith recently announced the launch of its new wellness supplement developed to assist individuals in maintaining energy, focus, and mindful appetite awareness as part of a balanced and active lifestyle. Manufactured in the United States in a facility that is FDA-registered and GMP-certified, the product is now available through official online channels. ProZenith is intended for individuals pursuing support for general weight management and overall well-being. Its formulation includes select ingredients chosen to align with healthy routines and support individuals seeking help managing non-hunger-related snacking behaviors. Each purchase of ProZenith is covered by a 60-day refund policy, reflecting the company's customer-first return assurance framework. All ProZenith supplements are manufactured without genetically modified ingredients and adhere to U.S. quality standards. Production takes place in an FDA-registered facility that complies with current Good Manufacturing Practices (cGMP). ProZenith is currently available through the company's official online platform at with multiple purchase options provided for convenience. About ProZenith ProZenith develops nutritional supplements designed to support individuals on their wellness journeys. The company emphasizes high-quality manufacturing, transparency, and customer satisfaction as it continues to expand its product offerings for health-conscious consumers. For customer support inquiries, contact: [email protected] Disclaimer: This product has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Media Contact: Company: ProZenith ProZenith Address: 19655 E 35th Dr #100, Aurora, CO 80011 19655 E 35th Dr #100, Aurora, CO 80011 Email: [email protected] [email protected] Order Phone Support: (925) 217-7353 Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.

RenovoRx (RNXT) PT Raised to $11.50 by Ascendiant on Strong Q1 2025 Results
RenovoRx (RNXT) PT Raised to $11.50 by Ascendiant on Strong Q1 2025 Results

Yahoo

timean hour ago

  • Yahoo

RenovoRx (RNXT) PT Raised to $11.50 by Ascendiant on Strong Q1 2025 Results

On Thursday, Ascendiant analyst Edward Woo raised the price target on RenovoRx Inc. (NASDAQ:RNXT) to $11.50 from $11, while maintaining a Buy rating on the shares. This adjustment follows the company's strong revenue growth reported in its Q1 2025 results. Woo indicated that the commercialization of RenovoCath and anticipated positive clinical data in Q3 will serve as strong catalysts for the stock. A clinical researcher in a lab examining a new biopharmaceutical product. The Q1 result includes ~$200K in revenue from commercial sales of RenovoCath alone. RenovoCath is an FDA-cleared and dual-balloon catheter device for the targeted isolation of blood flow and delivery of fluids. R&D expenses increased to $1.7 million, up from $1.3 million in Q1 2024, which was driven by higher employee compensation and manufacturing costs during the quarter. The company's Phase 3 TIGeR-PaC clinical trial showed promising results, with patients experiencing a median overall survival of 16 months using their targeted approach compared to 10 months with standard chemotherapy. There was also a 65% reduction in adverse events like nausea and fatigue. This trial is evaluating the company's proprietary TAMP therapy platform for the treatment of Locally Advanced Pancreatic Cancer. RenovoRx Inc. (NASDAQ:RNXT) is a clinical-stage biopharmaceutical company that develops targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment. While we acknowledge the potential of RNXT as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an extremely cheap AI stock that is also a major beneficiary of Trump tariffs and onshoring, see our free report on the best short-term AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store